Monitor for any upcoming earnings or pipeline catalysts that might explain the coordinated selling, but the dollar amount is immaterial relative to Takeda's size. This cluster is likely a routine pre-planned sale program and does not signal a change in business outlook.
TAK drugs
TAK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 13 $17.39entry
- T+1 · 3mo ago +1.38%α +1.58% · $17.63
- T+5 · 3mo ago +4.26%α +6.22% · $18.13
- T+20 · 2mo ago +5.00%α +6.75% · $18.26
- T+60 · 11d ago +20.87%α +26.35% · $21.02
Price Chart
How similar events traded
Executive Summary
A cluster of 4 Takeda insiders (including C-suite executives) sold shares on August 10, 2026, totaling $1.47M. The broader context shows 13 insiders sold the same day for ~$9.74M, but this is less than 0.02% of Takeda's $55.2B market cap, making the activity financially trivial. The coordinated same-price sales suggest a pre-planned program rather than opportunistic trading.
Key Financial Metrics
Key Facts
- 4 insiders sold shares on 2026-08-10 at $17.10 per share
- Total value of the cluster filing is $1.47M; cross-filing context reveals 13 insiders sold ~$9.74M on the same day
- Sales include the CEO, President of R&D, Chief Medical Officer, and other top executives
- Total sales represent <0.02% of Takeda's $55.2B market cap
- All trades occurred at the same price, consistent with a single execution or pre-arranged plan
Financial Impact
Total insider sales of $1.47M (filing) or $9.74M (including cross-filing context) are less than 0.02% of market cap, financially immaterial
Risk Factors
- No material risk identified from this cluster due to trivial dollar amount relative to market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TAK-1786586473408 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers